Real-World Clinical Outcomes of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Report of Two Cases From Mexico

Grecia Zavala Villafuerte, Ana G Perez-Romero, Ana B Crocker Sandoval

Open source

DOI
10.7759/cureus.114629
Published
2026-08-16
Container
Cureus
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.114629,
  title = {Real-World Clinical Outcomes of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Report of Two Cases From Mexico},
  author = {Grecia Zavala Villafuerte and Ana G Perez-Romero and Ana B Crocker Sandoval},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.114629},
  url = {https://doi.org/10.7759/cureus.114629}
}

RIS

TY  - JOUR
TI  - Real-World Clinical Outcomes of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Report of Two Cases From Mexico
AU  - Grecia Zavala Villafuerte
AU  - Ana G Perez-Romero
AU  - Ana B Crocker Sandoval
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.114629
UR  - https://doi.org/10.7759/cureus.114629
ER  - 

APA

Villafuerte, G. Z., Perez-Romero, A. G., & Sandoval, A. B. C. (2026). Real-World Clinical Outcomes of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Report of Two Cases From Mexico. Cureus. https://doi.org/10.7759/cureus.114629

Source records